Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: |
Title | Take Control of Hemophilia B | Rebinyn® Coagulation Factor IX (Recombinant), |
Description | APPROVED Rebinyn® is an injectable treatment used to replace clotting Factor IX in people with hemophilia B. It can be used as routine prophylaxis to reduce the number of bleeding episodes. Read important safety & prescribing |
Keywords | N/A |
WebSite | rebinyn.com |
Host IP | 72.3.137.119 |
Location | United States |
Site | Rank |
US$3,848,296
Last updated: 2023-05-14 03:28:34
rebinyn.com has Semrush global rank of 2,750,387. rebinyn.com has an estimated worth of US$ 3,848,296, based on its estimated Ads revenue. rebinyn.com receives approximately 444,035 unique visitors each day. Its web server is located in United States, with IP address 72.3.137.119. According to SiteAdvisor, rebinyn.com is safe to visit. |
Purchase/Sale Value | US$3,848,296 |
Daily Ads Revenue | US$3,553 |
Monthly Ads Revenue | US$106,569 |
Yearly Ads Revenue | US$1,278,819 |
Daily Unique Visitors | 29,603 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
rebinyn.com. | A | 299 | IP: 72.3.137.119 |
rebinyn.com. | NS | 86400 | NS Record: ns.rackspace.com. |
rebinyn.com. | NS | 86400 | NS Record: ns2.rackspace.com. |
rebinyn.com. | TXT | 300 | TXT Record: yk4yz535vknb27bcj5r9wg7fd16j2hwv |
rebinyn.com. | TXT | 300 | TXT Record: facebook-domain-verification=nt9dnz1cqhxqijfltzbep31wvzkjy8 |
rebinyn.com. | TXT | 300 | TXT Record: google-site-verification=69urxh7QPAlcE8M0_4ckpem2J8_V1tPawWaiszE_Los |
rebinyn.com. | TXT | 300 | TXT Record: 1x4h7wtkb3d58ssmrkw6c3sfzmqjqtn2 |
Prescribing Information Important Safety Information For Health Care Professionals About Novo Nordisk en Español Rebinyn® (Coagulation Factor IX [Recombinant], GlycoPEGylated) Home Why Rebinyn ® Preventing Bleeds Treating on Demand High Factor Levels Simple Dosing & Flexible Storage Protection in Surgery Community Stories Choosing Therapies Extending Half-Life How It Works Why It Matters Safety Considerations Starting Treatment Getting Your Factor Preparing for an Infusion Performing an Infusion Getting Support How We Can Help At a Glance Product Support Resources Contact Us APPROVED FOR ONCE-WEEKLY PROPHYLAXIS To prevent or reduce the number of bleeding episodes in people with hemophilia B Be ready for the unexpected Once-weekly Rebinyn ® helps you keep Factor 9 levels higher for longer. a APPROVED FOR ONCE-WEEKLY PROPHYLAXIS To prevent or reduce the number of bleeding episodes in people with hemophilia B BE READY FOR THE UNEXPECTED Once-weekly Rebinyn ® helps you keep Factor 9 |
HTTP/1.1 301 Moved Permanently Date: Wed, 22 Dec 2021 16:46:38 GMT Server: Apache/2.4.43 (IUS) OpenSSL/1.0.2k-fips Communique/4.3.2 Location: https://www.rebinyn.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 date: Wed, 22 Dec 2021 16:46:38 GMT server: Apache/2.4.43 (IUS) OpenSSL/1.0.2k-fips Communique/4.3.2 last-modified: Wed, 22 Dec 2021 14:49:52 GMT etag: "1af62-5d3bd3bfa49e3" accept-ranges: bytes content-length: 110434 vary: Accept-Encoding content-disposition: inline content-type: text/html; charset=UTF-8 |
Domain Name: REBINYN.COM Registry Domain ID: 1858323095_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.dynadot.com Registrar URL: http://www.dynadot.com Updated Date: 2021-05-13T04:28:54Z Creation Date: 2014-05-12T10:22:29Z Registry Expiry Date: 2022-05-12T10:22:29Z Registrar: DYNADOT, LLC Registrar IANA ID: 472 Registrar Abuse Contact Email: abuse@dynadot.com Registrar Abuse Contact Phone: +16502620100 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS.RACKSPACE.COM Name Server: NS2.RACKSPACE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T08:37:41Z <<< |